← ZEVRA THERAPEUTICS, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | ($16.5m) |
($43.4m)
-162.69%
|
($56.5m)
-30.15%
|
($24.5m)
+56.57%
|
($12.8m)
+47.97%
|
($8.6m)
+32.95%
|
($41.5m)
-385.60%
|
($46.0m)
-10.85%
|
($105.5m)
-129.13%
|
$83.2m
+178.88%
|
— | |
| Net Income (Loss) Available to Common Stockholders, Basic | ($16.5m) |
($43.4m)
-162.69%
|
($56.5m)
-30.15%
|
($24.5m)
+56.57%
|
($12.8m)
+47.97%
|
($62.9m)
-392.92%
|
($41.5m)
+33.95%
|
($46.0m)
-10.85%
|
($105.5m)
-129.13%
|
$77.6m
+173.53%
|
— | |
| Depreciation, Depletion and Amortization | $175k | $336k | $324k | $304k | $273k | $257k | $944k | $1.0m | $6.4m | $4.1m | $1.5m | |
| Depreciation | — | — | — | — | — | — | — | — | — | $200k | $1.5m | |
| Amortization of Debt Issuance Costs | $2.2m | $2.2m | $2.1m | — | — | — | — | — | — | — | — | |
| Amortization of Debt Issuance Costs and Discounts | $1.6m | $1.6m | $1.6m | $1.7m | $2.3m | $150k | $0 | — | — | — | — | |
| Amortization of Intangible Assets | — | — | — | — | — | — | — | $800k | $6.2m | $3.9m | — | |
| Depreciation and amortization expense | $175k | $336k | $324k | $304k | $273k | $257k | $944k | $1.0m | $6.4m | $4.1m | $1.5m | |
| Deferred Income Tax Expense (Benefit) | — | — | — | — | — | — | — | — | — | ($9.8m) | $7.7m | |
| Share-based Payment Arrangement, Noncash Expense | $6.6m | $4.6m | $6.5m | $4.4m | $2.5m | $2.4m | $4.3m | $6.0m | $14.9m | $12.6m | $13.1m | |
| Share-based Payment Arrangement, Expense | $6.6m | $4.6m | $6.5m | $4.4m | $2.5m | — | $4.3m | $6.0m | $14.9m | $12.6m | $13.1m | |
| Stock-based compensation expense | $6.6m | $4.6m | $6.5m | $4.4m | $2.5m | $2.4m | $4.3m | $6.0m | $14.9m | $12.6m | $13.1m | |
| Goodwill, Impairment Loss | — | — | — | — | — | — | — | $0 | $0 | $0 | $0 | |
| Impairment of Intangible Assets, Finite-lived | — | — | — | — | — | — | — | — | $0 | $58.7m | — | |
| Nonoperating Income (Expense) | $21.0m | ($10.1m) | ($689k) | ($4.2m) | ($7.2m) | ($16.2m) | $176k | $3.6m | ($3.1m) | $149.6m | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Accounts and other receivables | — | — | — | ($1.7m) | ($714k) | $1.1m | ($6.8m) | ($9.1m) | $6.9m | ($12.0m) | — | |
| Increase (Decrease) in Inventories | — | — | — | — | — | — | ($147k) | ($206k) | $8.9m | $1.3m | ($1.0m) | |
| Inventory Write-down | — | — | — | — | — | — | — | — | $5.7m | $11.7m | — | |
| Inventory obsolescence charge | — | — | — | — | — | — | — | $0 | $5.7m | $11.7m | — | |
| Inventories | — | — | — | — | — | $0 | $147k | $206k | ($8.9m) | ($1.3m) | ($1.0m) | |
| Accounts payable and accrued expenses | $1.1m | ($801k) | ($1.6m) | ($3.8m) | $931k | ($1.1m) | $3.1m | $11.1m | ($3.6m) | ($15.6m) | — | |
| Prepaid expenses and other current assets | $2.0m | ($926k) | ($548k) | $544k | $160k | ($825k) | ($657k) | $152k | ($2.2m) | ($2.9m) | — | |
| Other liabilities | $184k | $77k | ($102k) | ($798k) | $140k | $723k | ($371k) | $360k | $835k | ($1.2m) | — | |
| Net Cash Provided by (Used in) Operating Activities | ($29.8m) |
($33.1m)
-11.18%
|
($54.2m)
-63.76%
|
($23.7m)
+56.21%
|
($1.9m)
+91.83%
|
$10.4m
+638.37%
|
($18.7m)
-279.30%
|
($33.5m)
-79.17%
|
($69.7m)
-107.74%
|
($1.6m)
+97.71%
|
$33.4m
+2190.05%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $643k | $181k | $21k | $26k | $33k | $102k | $93k | $296k | $0 | $835k | ($775k) | |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | ($91k) | $284k | $52k | — | $17k | $0 | $9k | $157k | $218k | $448k | ($26.3m) | |
| Cash, Cash Equivalents, and Short-term Investments | — | — | — | — | — | — | — | $67.7m | — | — | — | |
| Payments to Acquire Investments | $89.8m | $27.4m | — | — | — | $15.4m | $22.5m | $45.8m | — | — | ($233.1m) | |
| Unrealized Gain (Loss) on Investments | — | — | — | — | — | ($13k) | ($577k) | $600k | $18.0b | $149k | $202k | |
| Accretion on investments | — | — | — | — | — | — | — | $0 | ($890k) | ($3.1m) | — | |
| Fair value adjustment related to investments | — | — | — | — | — | $0 | $577k | ($613k) | $18k | ($149k) | — | |
| Purchases of investments | — | — | — | — | — | — | ($23.9m) | ($45.8m) | ($41.2m) | ($310.0m) | — | |
| Maturities of investments | — | — | — | — | — | — | $1.3m | $59.1m | $25.0m | $178.5m | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | — | — | — | $14.1m | $30.4m | $0 | — | $0 | |
| Net Cash Provided by (Used in) Investing Activities | ($46.9m) | $27.4m | $33.3m | $3.2m | ($33k) | ($15.5m) | ($36.7m) | ($17.4m) | ($22.2m) | $18.1m | $106.7m | |
| Cash flows from financing activities: | ||||||||||||
| Gain (Loss) on Extinguishment of Debt | ($4.7m) | — | $2k | — | — | ($16.1m) | $0 | — | — | — | — | |
| Proceeds from Issuance of Long-term Debt | — | — | — | — | $781k | $0 | — | — | — | — | $0 | |
| Proceeds from issuance of debt, net of lender fees | $82.8m | — | — | — | — | $0 | $12.8m | $42.4m | $59.0m | $0 | $0 | |
| Repayment of debt | — | — | — | — | — | — | $0 | ($17.5m) | ($42.7m) | $0 | ($60.1m) | |
| Payments for Repurchase of Common Stock | — | — | — | — | — | $2.8m | $4.7m | $3.4m | $0 | — | — | |
| Proceeds from Issuance of Common Stock | — | — | — | — | — | — | — | $6.1m | $64.5m | $0 | $8.6m | |
| Consulting fees paid in common stock | — | — | — | — | $202k | $302k | $224k | $227k | $474k | $75k | — | |
| Proceeds from issuance of common stock for options exercised | — | — | $68k | — | — | — | — | $0 | $1.7m | $3.2m | $8.6m | |
| Proceeds from issuance of common stock for warrants exercised | $141k | $4k | $68k | — | $0 | $30.8m | $0 | — | $0 | $8.6m | $8.6m | |
| Net Cash Provided by (Used in) Financing Activities | $61.2m |
($203k)
-100.33%
|
$28.0m
+13902.46%
|
$4.9m
-82.37%
|
$2.7m
-44.54%
|
$113.1m
+4029.57%
|
$8.4m
-92.62%
|
$28.5m
+240.80%
|
$82.1m
+188.46%
|
$12.1m
-85.31%
|
($42.1m)
-449.33%
|
|
| Net increase (decrease) in cash and cash equivalents | ($15.6m) | ($5.9m) | $7.1m | ($15.6m) | $767k | $108.0m | ($46.9m) | ($22.4m) | ($9.3m) | $28.6m | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | ($5.9m) | $7.1m | ($15.6m) | $767k | $108.0m | ($46.9m) | ($22.4m) | ($9.3m) | $28.6m | $145.7m | |
| Cash and cash equivalents, beginning of period | $17.9m | $12.0m | $19.1m | $3.6m | $4.3m | $112.3m | $65.5m | $43.0m | $33.8m | $62.4m | — | |
| Loss on foreign currency exchange rates | — | — | — | — | — | $0 | ($91k) | ($198k) | $219k | $1.5m | — | |
| Effect of exchange rate changes on cash and cash equivalents | — | — | — | — | — | $0 | $204k | $44k | $454k | $28k | ($367k) | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | — | — | — | — | — | — | — | — | $1.7m | $3.2m | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $3.3m | $5.7m | $5.6m | $5.4m | $78k | $218k | $321k | $456k | $5.3m | $5.3m | — | |
| Additional Financial Items | ||||||||||||
| Foreign Currency Transaction Gain (Loss), before Tax | — | — | — | — | — | — | $91k | $198k | ($219k) | ($1.5m) | — | |
| Gain (Loss) on Disposition of Assets | — | ($104k) | — | — | — | — | — | — | — | — | — | |
| Gain (Loss) on Disposition of Intangible Assets | — | — | — | — | — | — | — | — | — | $148.3m | — | |
| General and Administrative Expense | $14.0m | $12.8m | $12.5m | $10.8m | $7.9m | $8.7m | $15.3m | — | — | — | — | |
| Goodwill | — | — | — | — | — | — | — | $4.7m | $4.7m | $4.7m | $0 | |
| Income Tax Expense (Benefit) | ($15k) | ($43k) | ($126k) | ($22k) | ($34k) | $34k | ($786k) | $0 | $15.4m | $3.4m | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $7.4m | $8.0m | — | |
| Operating Expenses | $37.5m | $33.4m | $55.9m | — | — | — | — | — | — | — | — | |
| Payments of Financing Costs | $164k | $50k | $184k | — | — | — | — | — | $2.1m | $0 | — | |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | — | $12.8m | $13.3m | $28.6m | $10.5m | $27.5m | $23.6m | $106.5m | — | |
| Income tax expense | — | — | — | — | — | — | — | $0 | $15.4m | $3.4m | — | |
| Non-cash interest expense | $2.2m | $2.2m | $2.1m | $1.4m | $4.7m | $8k | $0 | $0 | $2.1m | $2.6m | — | |
| Non-cash lease expense | — | — | — | — | — | — | — | — | $552k | $602k | — | |
| Fair value adjustment related to warrant and CVR liabilities | — | — | — | — | — | — | — | — | ($2.1m) | ($2.2m) | — | |
| Gain on sale of PRV | — | — | — | — | — | — | — | — | $0 | ($148.3m) | — | |
| Other long-term assets | — | — | — | — | — | $0 | $386k | ($5k) | $0 | $451k | — | |
| Discount and rebate liabilities | — | — | — | — | — | $0 | $3.8m | $3.2m | $431k | $6.7m | — | |
| Operating lease liabilities | — | — | — | $2.2m | ($271k) | ($326k) | ($389k) | ($439k) | ($626k) | ($675k) | — | |
| Proceeds from sale of PRV | — | — | — | — | — | — | — | — | $0 | $150.0m | — | |
| Payment of royalty to XOMA | — | — | — | — | — | — | — | $0 | ($6.0m) | $0 | — | |
| Proceeds from insurance financing arrangements | — | — | — | — | — | $0 | $1.3m | $1.3m | $1.1m | $0 | — | |
| Proceeds from Employee Stock Purchase Plan | — | — | — | — | — | $0 | $324k | $218k | $1.1m | $615k | — | |
| Proceeds from issuance of stock | — | — | $4.8m | — | — | — | $0 | $6.1m | $64.5m | $0 | — | |
| Payments of principal on insurance financing arrangements | — | — | — | — | — | $0 | ($1.3m) | ($564k) | ($431k) | ($372k) | — | |
| Payment of deferred financing costs | ($164k) | ($50k) | ($184k) | — | — | — | — | $0 | ($2.1m) | $0 | — | |
| Right-of-use assets obtained in exchange for lease liabilities | — | — | — | — | — | $0 | $123k | $0 | $0 | $1.1m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.